SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-001645
Accepted
2021-05-03 00:15:21
Documents
1
Effectiveness Date
2021-04-30
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 605
  Complete submission text file 9999999995-21-001645.txt   1905
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: EFFECT | Act: 33 | File No.: 333-233048 | Film No.: 21881060
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences